The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Elepsia Xr 1000 Mg
levetiracetam · LEVETIRACETAM 1000 mg/1 · Tablet, Extended Release · Oral · Tripoint Therapeutics, Llc
NDC 80705-0100-02 · 1 BLISTER PACK in 1 CARTON / 2 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for levetiracetam (oral solid) in the next 90 days
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA204417
- TE code
- —
- Approval date
- Dec 20, 2018
- Patents / exclusivity
- 10 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 8470367 | Oct 31, 2027 |
| patent | 8431156 | Oct 31, 2027 |
| patent | 8470367 | Oct 31, 2027 |
| patent | 8431156 | Oct 31, 2027 |
| patent | 8163306 | Sep 3, 2027 |
| patent | 8163306 | Sep 3, 2027 |
| patent | 8535717 | Feb 22, 2026 |
| patent | 8425938 | Feb 22, 2026 |
| patent | 8535717 | Feb 22, 2026 |
| patent | 8425938 | Feb 22, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of levetiracetam (Tablet, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| BluePoint Laboratories | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals, Inc. | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals, Inc. | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Omnivium Pharmaceuticals LLC | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Omnivium Pharmaceuticals LLC | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Torrent Pharmaceuticals Limited | LEVETIRACETAM 750 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Torrent Pharmaceuticals Limited | LEVETIRACETAM 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Tripoint Therapeutics, Llc | LEVETIRACETAM 1500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Tripoint Therapeutics, Llc | LEVETIRACETAM 1000 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Elepsia Xr 1000 Mg — NDC 80705-0100-02," retrieved September 3, 2026, https://drugdashboards.com/drug/80705010002.
Free to cite with attribution — see how the data is put together.